{"id":456705,"date":"2021-03-12T07:03:33","date_gmt":"2021-03-12T12:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456705"},"modified":"2021-03-12T07:03:33","modified_gmt":"2021-03-12T12:03:33","slug":"cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/","title":{"rendered":"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">SEATTLE<\/span>, <span class=\"xn-chron\">March 12, 2021<\/span> \/PRNewswire\/ &#8212; CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its fourth quarter and full year 2020 financial results on <span class=\"xn-chron\">Wednesday, March 17, 2021<\/span>, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a conference call and webcast to discuss the results and provide a general corporate update at <span class=\"xn-chron\">4:30 p.m. ET<\/span> (<span class=\"xn-chron\">1:30 p.m. PT<\/span>).<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg\" title=\"CTI BioPharma Corp. Logo (PRNewsFoto\/Cell Therapeutics, Inc.)\" alt=\"CTI BioPharma Corp. Logo (PRNewsFoto\/Cell Therapeutics, Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>To access the live call by phone please dial (877) 735-2860 (domestic) or (602) 563-8791 (international); the conference ID is 9095063. A live audio webcast of the event may also be accessed through the &#8220;Investors&#8221; section of CTI&#8217;s website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3095066-1&amp;h=1642706266&amp;u=http%3A%2F%2Fwww.ctibiopharma.com%2F&amp;a=www.ctibiopharma.com\" rel=\"nofollow noopener noreferrer\">www.ctibiopharma.com<\/a>. A replay of the webcast will be available for 30 days following the <span id=\"spanHghlt8327\">event.<\/span><\/p>\n<p>\n        <b>About CTI BioPharma Corp.<br \/><\/b>We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis. In addition, we have recently started developing pacritinib for use in hospitalized patients with severe COVID-19, in response to the COVID-19 pandemic. We are headquartered in <span class=\"xn-location\">Seattle, Washington<\/span>.<\/p>\n<p>\n        <b>CTI BioPharma Investor Contacts:<br \/><\/b><br \/>\n        <span class=\"xn-person\">Maeve Conneighton<\/span>\/<span class=\"xn-person\">Maghan Meyers<\/span><br \/>+212-600-1902<br \/><a target=\"_blank\" href=\"mailto:cti@argotpartners.com\" rel=\"nofollow noopener noreferrer\">cti@argotpartners.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF07652&amp;sd=2021-03-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021-301246156.html\">http:\/\/www.prnewswire.com\/news-releases\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021-301246156.html<\/a><\/p>\n<p>SOURCE  CTI BioPharma Corp.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF07652&amp;Transmission_Id=202103120700PR_NEWS_USPR_____SF07652&amp;DateId=20210312\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire SEATTLE, March 12, 2021 \/PRNewswire\/ &#8212; CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its fourth quarter and full year 2020 financial results on Wednesday, March 17, 2021, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a conference call and webcast to discuss the results and provide a general corporate update at 4:30 p.m. ET (1:30 p.m. PT). To access the live call by phone please dial (877) 735-2860 (domestic) or (602) 563-8791 (international); the conference ID is 9095063. A live audio webcast of the event may also be accessed through the &#8220;Investors&#8221; section of CTI&#8217;s website at www.ctibiopharma.com. A replay of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456705","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SEATTLE, March 12, 2021 \/PRNewswire\/ &#8212; CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its fourth quarter and full year 2020 financial results on Wednesday, March 17, 2021, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a conference call and webcast to discuss the results and provide a general corporate update at 4:30 p.m. ET (1:30 p.m. PT). To access the live call by phone please dial (877) 735-2860 (domestic) or (602) 563-8791 (international); the conference ID is 9095063. A live audio webcast of the event may also be accessed through the &#8220;Investors&#8221; section of CTI&#8217;s website at www.ctibiopharma.com. A replay of &hellip; Continue reading &quot;CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-12T12:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021\",\"datePublished\":\"2021-03-12T12:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/\"},\"wordCount\":275,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/92552\\\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/\",\"name\":\"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/92552\\\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg\",\"datePublished\":\"2021-03-12T12:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/92552\\\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/92552\\\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/","og_locale":"en_US","og_type":"article","og_title":"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 - Market Newsdesk","og_description":"PR Newswire SEATTLE, March 12, 2021 \/PRNewswire\/ &#8212; CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its fourth quarter and full year 2020 financial results on Wednesday, March 17, 2021, after the close of the U.S. financial markets. Following the announcement, members of the management team will host a conference call and webcast to discuss the results and provide a general corporate update at 4:30 p.m. ET (1:30 p.m. PT). To access the live call by phone please dial (877) 735-2860 (domestic) or (602) 563-8791 (international); the conference ID is 9095063. A live audio webcast of the event may also be accessed through the &#8220;Investors&#8221; section of CTI&#8217;s website at www.ctibiopharma.com. A replay of &hellip; Continue reading \"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-12T12:03:33+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021","datePublished":"2021-03-12T12:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/"},"wordCount":275,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/","name":"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg","datePublished":"2021-03-12T12:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/92552\/cell_therapeutics_inc_cti_biopharma_corp_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cti-biopharma-to-report-fourth-quarter-and-full-year-2020-financial-results-on-march-17-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CTI BioPharma to Report Fourth Quarter and Full Year 2020 Financial Results on March 17, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456705"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456705\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}